Advancements in Genitourinary Oncology: Key Takeaways from AUA 2026

Advancements in Genitourinary Oncology: Key Takeaways from AUA 2026

Clinical Breakthroughs in GU Malignancies Urological oncology experts gathered at the 2026 American Urological Association (AUA) Annual Meeting to unveil transformative data regarding the treatment of genitourinary (GU) cancers, emphasizing significant progress in bladder cancer protocols and novel immunotherapies. This year’s conference highlighted a paradigm shift in patient management, focusing heavily on the integration of…

Read More